Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    11786451 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD
Condition: Peripheral Artery Disease
Interventions: Drug: Short DAPT;   Drug: Long DAPT
2 Recruiting Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM
Condition: Ischemic Stroke
Interventions: Drug: Naoxintong Capsule;   Drug: Placebo
3 Completed The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Acetaminophen - 4 grams per day + Placebo;   Drug: Aspirin - 325 mg per day + Placebo;   Drug: Acetaminophen 4 gram per day + Aspirin 325 mg per day
4 Completed Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
Conditions: Coronary Heart Disease;   Angina Pectoris;   Atherosclerosis
Interventions: Drug: aspirin;   Drug: clopidogrel
5 Recruiting WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW - ACS)
Condition: Acute Coronary Syndrome
Intervention: Drug: Aspirin
6 Completed Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence
Conditions: Acute Coronary Syndrome;   Coronary Artery Disease;   Ischemic Stroke;   Peripheral Artery Disease;   Carotid Artery Disease;   Atrial Fibrillation
Intervention:
7 Completed
Has Results
Prevention of Ischemic Events in Patients With Peripheral Arterial Disease
Condition: Peripheral Arterial Disease
Intervention: Other: Implementation of the European Guidelines on cardiovascular Disease Prevention in Clinical Practice
8 Not yet recruiting Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease;   Diabetes Mellitus, Type 2
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Aspirin
9 Recruiting ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)
Condition: Atherothrombosis
Interventions: Drug: Aspirin;   Drug: Triflusal
10 Completed Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
Condition: Myocardial Infarction
Interventions: Drug: FDC;   Drug: Separately drugs, simvastatin, aspirin and ramipril

Study has passed its completion date and status has not been verified in more than two years.